EODData

MEMBERSHIP REGISTER LOG IN

LSE, 0WA2: Cellectis Ord Shs

09 Oct 2026
LAST:

1.140

CHANGE:
 0.02		OPEN:
1.126		HIGH:
1.140		ASK:
1.828		VOLUME:
122
CHG(%):
1.97		PREV:
1.118		LOW:
1.120		BID:
1.740		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Oct 261.1261.1401.1201.140122
08 Oct 261.2401.2401.1181.118152
07 Oct 261.2241.2241.1911.224100
06 Oct 261.2821.2821.2331.233100
05 Oct 261.2501.2501.2431.243100
02 Oct 261.2751.2771.2501.2601.7K
01 Oct 261.3011.3251.2811.284262
30 Sep 261.3041.3511.3041.316100
29 Sep 261.2791.2891.2321.236100
28 Sep 261.2841.2841.2551.2671.6K

PROFILE

Name:Cellectis Ord Shs
About:Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing ALLO-501 to treat large B-cell lymphoma; ALLO-316, a gene-edited allogeneic CAR T-cell product targeting CD70; ALLO-819 to treat acute myeloid leukemia; ALLO-213 for the treatment of small cell lung cancer; and ALLO-182 to treat gastric and pancreatic cancer. It also develops UCART22 for the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia; UCART123 to treat acute myeloid leukemia; UCART 20x22 for relapsed or refractory B-Cell non-hodgkin's lymphoma; and cema-cel to treat relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma. The company was founded in 1999 and is headquartered in Paris, France.
Address:8, rue de la Croix Jarry, Paris, France, 75013
Website:https://www.cellectis.com

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.33 
PEG Ratio:0.10 
Price to Sales:8.42 
Price to Book:5.34 
Profit Margin:0.87 
Operating Margin:-3.20 
Return on Assets:-0.18 
Return on Equity:-0.63 
Revenue:21.15M 

TECHNICAL INDICATORS

MA5:1.194.5%
MA10:1.238.1%
MA20:1.2610.9%
MA50:2.1689.1%
MA100:2.41111.6%
MA200:2.87152.1%
STO9:9.44 
STO14:6.88 
RSI14:38.85 
WPR14:-92.54 
MTM14:-0.27
ROC14:-0.19 
ATR:0.07 
Week High:1.2812.5%
Week Low:1.122.0%
Month High:2.84149.5%
Month Low:1.10152.1%
Year High:4.84324.6%
Year Low:1.103.6%
Volatility:15.17